Radiopharmaceutical therapy using 177 Lu-prostate-specific membrane antigen (PSMA) is
an effective prostate cancer treatment that was recently approved by the US Food and Drug …

We report our initial real-world experience with 177 Lu-PSMA-617 radioligand therapy.
Methods: We performed a retrospective review of patients treated with 177 Lu-PSMA-617. …

P1222 Introduction: 177 Lu-PSMA-617 is a radioligand with high affinity for prostate-specific
membrane antigen (PSMA), enabling targeted β-irradiation of prostate cancer. We aimed to …

P1249 Introduction: Despite the market availability of both 18 F-DCFPyL (DCFPyL,
PYLARIFY®) and 68 Ga-PSMA-11 (LOCAMETZ TM ) radiotracers, the 177 Lu-PSMA-617 (vipivotide …

Objective Medical student knowledge about brain death determination is limited. We describe
an educational initiative to improve medical student awareness about brain death and …

Background Few programs train residents in recognizing and responding to distressed
colleagues at risk for suicide. Aim To assess interns’ ability to identify a struggling colleague, …

Background Physicians across specialties need to be skilled at diagnosing and treating
depression, yet studies show underrecognition and inadequate treatment. Understanding the …

There is hope that ctDNA can be used to inform decisions about adjuvant therapy for patients
with cancer following primary surgery or radiation treatment, because it is not always clear …

A systematic review and subset meta-analysis of published randomised controlled trials of
psychological therapies for children and adolescents with chronic pain is reported. A search …

Introduction Despite a decline, smoking rates have remained high, especially in communities
with lower income, education, and limited insurance options. Evidence shows that …